Last reviewed · How we verify
NCT03962751: MC2 Pilot
Motivating Campus Change Project Pilot Study
NA trial testing Simultaneous Post Feedback Intervention Delivery in Drinking Behavior in 250 participants. Completed in 4 November 2018.
4 November 2018
Quick facts
| Lead sponsor | University of Washington |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 250 |
| Start date | 28 June 2018 |
| Primary completion | 4 November 2018 |
| Estimated completion | 4 November 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Simultaneous Post Feedback Intervention Delivery
- Sequential Post Feedback Intervention Delivery
- Text Message Boosters
Conditions studied
- Drinking Behavior — all drugs for Drinking Behavior →
Sponsor
University of Washington
Who can join
Adults 18 to 24, any sex, with Drinking Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study tests the optimization and delivery feasibility of personalized feedback interventions to address harmful alcohol use among college students.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03962751
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Drinking Behavior
Currently open trials in the same condition.
- NCT06415721 — Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder · NA · recruiting
- NCT06994962 — Multi-Component Breath Alcohol Intervention Phase 3 · NA · recruiting
- NCT06124898 — Multi-Component Breath Alcohol Intervention · NA · active not recruiting
- NCT05609344 — Barbershop Talk: Reducing Excessive Alcohol Consumption Among Men · NA · active not recruiting
- NCT05414344 — A Brief Intervention for Alcohol Users With Interpersonal Trauma · NA · active not recruiting
Other University of Washington trials
Trials by the same sponsor.
- NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
- NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
- NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
- NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
- NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03962751 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Washington
- Last refreshed: 16 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03962751.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing